GUANGZHOU KINGMED DIAGNOST

Guangzhou Kingmed Diagnostics (603882.SS): flat 0% today, but up 3.61% month‑over‑month. Learn about its market cap, liquidity, and role in China’s healthcare diagnostics.

Guangzhou Kingmed Diagnostics discontinues its HK JV, boosts cost‑leadership and testing portfolio amid flat stock performance.

Guangzhou Kingmed Diagnostics: track its unchanged 2026 share price, 1.53% monthly rise, 13.1 bn market cap, and peer comparisons for informed investing.